PROCEPT BioRobotics Corporation - Common Stock (PRCT)

22.69
-5.15 (-18.50%)
NASDAQ · Last Trade: Feb 26th, 1:44 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
There are notable gap-ups and gap-downs in today's session.chartmill.com
Via Chartmill · February 26, 2026
Get insights into the top gainers and losers of Thursday's pre-market session.chartmill.com
Via Chartmill · February 26, 2026
PROCEPT BioRobotics Stock Hits 52-Week Low - Here's Whybenzinga.com
PROCEPT BioRobotics (NASDAQ: PRCT) shares down on Q4 2025 results and updated revenue guidance. Q1 sales expected at $79-82 million.
Via Benzinga · February 26, 2026
PRCT Stock Tumbles Pre-Market: BofA Questions Earnings Visibility, Cuts Target To $20stocktwits.com
Bank of America reduced its rating on PROCEPT BioRobotics to ‘Underperform’ from ‘Neutral’.
Via Stocktwits · February 26, 2026
PROCEPT BioRobotics Corp (NASDAQ:PRCT) Plummets 27% After Q4 Earnings Miss and Slashed 2026 Guidancechartmill.com
Via Chartmill · February 25, 2026
Earnings Scheduled For November 4, 2025benzinga.com
Via Benzinga · November 4, 2025
Earnings Scheduled For August 6, 2025benzinga.com
Via Benzinga · August 6, 2025
Where PROCEPT BioRobotics Stands With Analystsbenzinga.com
Via Benzinga · April 25, 2025
Earnings Scheduled For April 24, 2025benzinga.com
Via Benzinga · April 24, 2025
Top movers in Wednesday's after hours sessionchartmill.com
Via Chartmill · February 25, 2026
After a 60% Slide, One Fund Cuts Exposure to This Healthcare Tech Stock by $12.5 Millionfool.com
This healthcare technology firm develops robotic surgical systems for minimally invasive urology procedures targeting BPH treatment.
Via The Motley Fool · February 1, 2026
3 Underrated Robotics Stocks Poised for Huge Gainsmarketbeat.com
Via MarketBeat · December 15, 2025
2 Robotics Stocks Riding the Sensor and Medical Boomfool.com
The robotics infrastructure layer is delivering explosive returns.
Via The Motley Fool · October 29, 2025
4 Analysts Assess PROCEPT BioRobotics: What You Need To Knowbenzinga.com
Via Benzinga · February 26, 2025
Earnings Scheduled For February 25, 2025benzinga.com
Via Benzinga · February 25, 2025
How Is The Market Feeling About PROCEPT BioRobotics?benzinga.com
Via Benzinga · January 24, 2025
Is Procept BioRobotics Stock a Buy After Investment Company Chicago Capital Scoops Up Nearly 1 Million Shares?fool.com
Is Procept BioRobotics Stock a Buy After Investment Company Chicago Capital Scoops Up Nearly 1 Million Shares?
Via The Motley Fool · October 24, 2025
Beyond The Numbers: 4 Analysts Discuss PROCEPT BioRobotics Stockbenzinga.com
Via Benzinga · October 15, 2025
Assessing PROCEPT BioRobotics: Insights From 4 Financial Analystsbenzinga.com
Via Benzinga · September 2, 2025
Procept (PRCT) Q2 Revenue Jumps 48%fool.com
Via The Motley Fool · August 6, 2025
PROCEPT BioRobotics (PRCT) Earnings Transcriptfool.com
Via The Motley Fool · August 6, 2025
PROCEPT BioRobotics Corp. (NASDAQ:PRCT) Reports Q2 2025 Revenue Growth but Misses Profitability Targets, Triggering After-Hours Declinechartmill.com
PROCEPT BioRobotics posted strong Q2 2025 revenue growth of 48% YoY but missed profitability estimates, triggering an 8% stock drop. The surgical robotics firm raised full-year guidance but faces investor concerns over rising costs and ongoing losses.
Via Chartmill · August 6, 2025
Uncovering Potential: PROCEPT BioRobotics's Earnings Previewbenzinga.com
Via Benzinga · August 5, 2025
Spruce Point Sees Trouble Ahead For Procept BioRoboticsbenzinga.com
Spruce Point Capital warns of Procept BioRobotics' overstated market potential and growth claims, citing niche product limitations and valuation risks.
Via Benzinga · January 16, 2025
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukosbenzinga.com
Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges.
Via Benzinga · December 2, 2024